San Francisco, 4 January 2019: The Report Bariatric Surgery Devices Market Size, Share &
Trends Analysis Report By Procedures (Adjustable Gastric Band, Vertical Sleeve
Gastrectomy, Roux-en-Y Gastric Bypass), And Segment Forecasts, 2012 - 2022
The global bariatric surgery devices market is
expected to reach USD 2.8 billion by 2022, according to a new report by Grand
View Research, Inc. The growing incidence rate of obesity has led to many government
initiatives at regional as well as global level to increase the awareness
related to obesity and undertake various incidence curbing action plans. For
instance, the South Wales government launched the NSW Healthy Eating and Active
Living Strategy 2013-2018 for preventing obesity.
In addition, to
strategic planning, the governments of developed nations are also funding
universities to design strategic interventions to control the rising obesity.
For the year 2014, New Zealand invested USD 40 million for its Healthy Families
NZ anti-obesity initiative. Moreover, industry players are also trying to
tackle the rising problem of obesity by launching new products. In February
2017, a startup company, Allurion Technologies, located in Massachusetts, U.S.
filed a regulatory filing to report the USD 19 million raised amount out of the
target of USD 27 million. The funds were intended to use for the development
non-endoscopic gastric balloon, Ellipse. This device is in the form of capsule
which when swallowed, is inflated in the stomach and deflates after months and
is passed out without the need for anesthesia for its removal. This device is
anticipated to revolutionize the bariatric surgery devices market due to its
ease of use over the forecast period
The demand for
non-invasive surgeries is also increasing, as non-invasive surgeries save time,
cost, and decrease hospital stay. Governments are also encouraging the use of
more incisionless surgeries in order to decrease the cases of infection. For
instance, in July 2015, the FDA approved a balloon device, where the balloon is
directly swallowed using a sterile solution.
Access Research Report of Bariatric Surgery Devices Market @
www.grandviewresearch.com/industry-analysis/bariatric-surgery-devices-industry
Further Key Findings from the Report Suggest:
· Gastric bypass surgery dominated the market
in 2014 due to its early adoption since 1960 and the fact that it is the
combination of both restrictive and malabsorptive procedures.
· The sleeve gastrectomy surgery is expected
to witness rapid rise in demand owing to, the procedure's incision-less nature.
The fact that the procedure does not involve re-routing the intestine is also
likely to drive segment growth. With the FDA approval of ReShape balloon, there
has been a recent FDA filing for Ellipse device, which is swallowed and gets
excreted naturally after four months.
· North America was the largest regional
market owing to the presence of market players introducing innovative
technologies to improve patient care.
· Favorable government initiatives are also
expected to play pivotal roles in the European market growth. For instance, the
German Federal Ministry of Education and Research (BMBF) formed two funding
research programs namely the Competence Network Obesity and Integrated Research
and Treatment Center (IFB) Adiposity Diseases with budgets allocated at around
USD 26 million for 2012-2015.
· Asia Pacific followed North America in
terms of obesity and overweight prevalence. This coupled with the presence of
large untapped opportunities is expected to help the Asia Pacific bariatric
surgery market register the fastest growth over the forecast period.
· Some key players of this market include
Covidien Plc, Intuitive Surgical Inc., TransEnterix Inc., Allergan Inc., USGI
Medical Inc., Semiled Ltd., Cousin Biotech, GI Dynamics Inc., Johnson and
Johnson and Mediflex Surgical Product.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the bariatric surgery devices market report on the basis of
procedures:
Procedure Outlook (Revenue, USD Million, 2012 - 2022)
·
Adjustable Gastric Band (AGB)
·
Vertical Sleeve Gastrectomy (VSG)
·
Roux-en-Y Gastric Bypass (RYGB)
·
Biliopancreatic Diversion with a Duodenal
Switch (BPD-DS)
Regional Outlook (Revenue, USD Million, 2012 - 2022)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Access Press Release of
Bariatric Surgery Devices Market@ www.grandviewresearch.com/press-release/global-bariatric-surgery-devices-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment